Page last updated: 2024-08-23

flupirtine and Neuronal Ceroid-Lipofuscinoses

flupirtine has been researched along with Neuronal Ceroid-Lipofuscinoses in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Augustine, EF; Mink, JW	1
Adams, H; Augustine, EF; Cialone, J; de Blieck, EA; Kwon, J; Marshall, FJ; Mink, JW; Newhouse, N; Rothberg, PG; Vierhile, A	1
Amalfitano, A; Bitting, RL; Boustany, RM; Dhar, S; Jansen, PJ; Koeberl, DD; Lockhart, E; Rylova, SN	1

Reviews

1 review(s) available for flupirtine and Neuronal Ceroid-Lipofuscinoses

Article	Year
Juvenile NCL (CLN3 Disease): Emerging Disease-Modifying Therapeutic Strategies. Pediatric endocrinology reviews : PER, 2016, Volume: 13 Suppl 1 Topics: Aminopyridines; Anti-Inflammatory Agents; Genetic Therapy; Humans; Immunosuppressive Agents; Membrane Glycoproteins; Molecular Chaperones; Mycophenolic Acid; Neuronal Ceroid-Lipofuscinoses; Prednisone	2016

Other Studies

2 other study(ies) available for flupirtine and Neuronal Ceroid-Lipofuscinoses

Article	Year
Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data. Journal of inherited metabolic disease, 2011, Volume: 34, Issue:5 Topics: Adolescent; Adult; Algorithms; Aminopyridines; Analgesics; Child; Child, Preschool; Female; Follow-Up Studies; Health Surveys; Humans; Infant; Male; Neuronal Ceroid-Lipofuscinoses; Parents; Reproducibility of Results; Research Design; Research Report; Treatment Outcome; Young Adult	2011
Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons. Annals of neurology, 2002, Volume: 51, Issue:4 Topics: Aminopeptidases; Aminopyridines; Apoptosis; Cell Division; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Endopeptidases; Gene Expression; Humans; In Situ Nick-End Labeling; In Vitro Techniques; Lymphocytes; Membrane Glycoproteins; Membrane Proteins; Mitosis; Molecular Chaperones; Neuronal Ceroid-Lipofuscinoses; Neurons; Neuroprotective Agents; Peptide Hydrolases; Proteins; RNA, Messenger; Serine Proteases; Teratocarcinoma; Thiolester Hydrolases; Transfection; Tripeptidyl-Peptidase 1; Tumor Cells, Cultured	2002

Article

Year

Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data.

Journal of inherited metabolic disease, 2011, Volume: 34, Issue:5

Topics: Adolescent; Adult; Algorithms; Aminopyridines; Analgesics; Child; Child, Preschool; Female; Follow-Up Studies; Health Surveys; Humans; Infant; Male; Neuronal Ceroid-Lipofuscinoses; Parents; Reproducibility of Results; Research Design; Research Report; Treatment Outcome; Young Adult

2011

Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons.

Annals of neurology, 2002, Volume: 51, Issue:4

Topics: Aminopeptidases; Aminopyridines; Apoptosis; Cell Division; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Endopeptidases; Gene Expression; Humans; In Situ Nick-End Labeling; In Vitro Techniques; Lymphocytes; Membrane Glycoproteins; Membrane Proteins; Mitosis; Molecular Chaperones; Neuronal Ceroid-Lipofuscinoses; Neurons; Neuroprotective Agents; Peptide Hydrolases; Proteins; RNA, Messenger; Serine Proteases; Teratocarcinoma; Thiolester Hydrolases; Transfection; Tripeptidyl-Peptidase 1; Tumor Cells, Cultured

2002